Your search for comorbidities returned 124 results

Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.

Researchers sought to assess clinical outcomes and 30-day readmission rates for patients with cardiorenal syndrome and HFrEF.

Researchers sought to determine use of guideline-directed medical therapies for heart failure in real-world settings in Japan, Sweden, and the United States.

A study was conducted to determine the relationship between obesity in male adolescence and development of atrial fibrillation later in life.

A study was conducted to determine if relaxin-2 is an indicator of prognosis in patients with chronic heart failure with preserved ejection fraction.

A study was conducted to determine the effect of age differences on clinical outcomes following sacubitril/valsartan therapy for patients with HFrEF.

Researchers evaluated dapagliflozin and empagliflozin eligibility in real-world patients with heart failure based on clinical trial criteria.

Researchers sought to determine unique phenotypes for patients with heart failure or that may be at risk for developing heart failure.

A study was conducted to determine if physiologic determinants of NT-proBNP concentrations account for sex and race differences.

Investigators sought to determine the effect of empagliflozin on LV contractile reserve in patients with HFrEF.